Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression

被引:0
|
作者
Robert Hyman
机构
[1] Molecular and Cell Biology Laboratory,
[2] Salk Institute,undefined
[3] Box 85800,undefined
[4] San Diego,undefined
[5] CA 92186-5800,undefined
[6] USA,undefined
来源
Immunogenetics | 2002年 / 53卷
关键词
CD44 Methylation Promoter Gene expression;
D O I
暂无
中图分类号
学科分类号
摘要
Methylation of the CD44 promoter at one or more CpG dinucleotides has been proposed as being important in the control of CD44 expression. In vitro methylation of all CpGs occurring between bases –1 to –1374 upstream of the position of translation initiation repressed the promoter activity of mouse CD44 4.5- to 12-fold in transient transfection experiments. Assaying the methylation of these 29 CpGs by genomic sequencing using differential base modification by sodium bisulfite indicated that a cluster of three CpGs immediately upstream of the position of translation initiation was heavily methylated in the mouse CD44-negative T-cell lymphoma AKR1. All 19 CpGs between bases –4 and –447, including the cluster heavily methylated in AKR1, were demethylated in the CD44-positive T-cell lymphoma BW5147, while CpGs further upstream showed no change in methylation pattern. The cluster of heavily methylated CpGs remained methylated, however, when CD44 was activated by transient transfection of c-jun into an AKR1 subline expressing polyoma large-T or by treatment of this subline with sodium butyrate, and no significant demethylation of other CpGs was observed. It is concluded, therefore, that no consistent demethylation event in the promoter-containing region encompassing the 1374 base pairs upstream of the position of CD44 translation initiation is required for CD44 expression.
引用
收藏
页码:914 / 924
页数:10
相关论文
共 50 条
  • [31] CD44 AND METASTASIS
    ZOLLER, M
    KAUFMANN, M
    ONKOLOGIE, 1994, 17 (02): : 114 - 122
  • [32] CD44 in cancer
    Naor, D
    Nedvetzki, S
    Golan, I
    Melnik, L
    Faitelson, Y
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2002, 39 (06) : 527 - 579
  • [33] CD44 and Fas
    Thomas Pap
    Arthritis Research & Therapy, 3 (1)
  • [34] Homing in on CD44
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2006, 6 : 832 - 832
  • [35] Intracellular Domain Fragment of CD44 Alters CD44 Function in Chondrocytes
    Mellor, Liliana
    Knudson, Cheryl B.
    Hida, Daisuke
    Askew, Emily B.
    Knudson, Warren
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (36) : 25838 - 25850
  • [36] CD44 AND CD44 SPLICE VARIANTS IN NORMAL DIFFERENTIATION AND IN TUMOR PROGRESSION
    HERRLICH, P
    HOFMANN, M
    ZOLLER, M
    RUDY, W
    ARCH, R
    HEIDER, KH
    TOLG, C
    PONTA, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 330 - 330
  • [37] Defining roles for the CD44 cytoplasmic domain in regulating CD44 function
    Peterson, RS
    Knudson, W
    Wang, WH
    Knudson, CB
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 192A - 192A
  • [38] Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer
    Kawano, T
    Yanoma, S
    Nakamura, Y
    Ozeki, A
    Kokatsu, T
    Kubota, A
    Furukawa, M
    Tsukuda, M
    ACTA OTO-LARYNGOLOGICA, 2005, 125 (04) : 392 - 397
  • [39] CD44 and CD44v6 expression in osteosarcoma (OS).
    Reith, J
    Casanova, J
    Scarborough, M
    MODERN PATHOLOGY, 2001, 14 (01) : 18A - 18A
  • [40] CD44 and CD44v6 expression in osteosarcoma (OS).
    Reith, J
    Casanova, J
    Scarborough, M
    LABORATORY INVESTIGATION, 2001, 81 (01) : 18A - 18A